Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms - PubMed (original) (raw)
. 2000 Dec 14;19(54):6351-60.
doi: 10.1038/sj.onc.1204025.
Affiliations
- PMID: 11175350
- DOI: 10.1038/sj.onc.1204025
Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms
M Lu et al. Oncogene. 2000.
Abstract
We have evaluated the transcriptional activation of a human p21 promoter reporter construct by transfection of BRCA1 expression constructs into tumorigenic and nontumorigenic human breast cell lines. Two cell lines with wildtype p53 (MCF-7 and MCF10A) demonstrated transcriptional activation of the p21 promoter by full-length BRCA1 (BRCA1L) as well as by two splice variants that lack most of exon 11 (BRCA1S and BRCA1S-9,10). In contrast, two cell lines with mutant p53 (MDA-231 and HCC1937) were inactive. Co-transfection of BRCA1L with BRCA1S or BRCA1S-9,10 exhibited synergistic p21 promoter activation, due to augmented expression of the cytomegalovirus promoter-based BRCA1 expression constructs. We examined the transcriptional activity of two known sequence alterations in BRCA1, one that results in a carboxy-terminal truncation of BRCA1 and is clearly pathogenic, and the other a missense mutation that is suspected of predisposing to cancer. Although both mutations have been shown to be defective in some assays of transactivation, we observed both mutations to be fully active in activation of the p21 promoter when incorporated in the full-length BRCA1L. In contrast, these mutations rendered BRCA1S inactive. These observations indicate that such transcriptional assays cannot serve as the basis for a functional appraisal of BRCA1 sequence alterations encountered in the course of genetic testing.
Similar articles
- BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
Randrianarison V, Marot D, Foray N, Cabannes J, Méret V, Connault E, Vitrat N, Opolon P, Perricaudet M, Feunteun J. Randrianarison V, et al. Cancer Gene Ther. 2001 Oct;8(10):759-70. doi: 10.1038/sj.cgt.7700366. Cancer Gene Ther. 2001. PMID: 11687899 - BRCA1 physically associates with p53 and stimulates its transcriptional activity.
Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, Weber BL, El-Deiry WS. Zhang H, et al. Oncogene. 1998 Apr 2;16(13):1713-21. doi: 10.1038/sj.onc.1201932. Oncogene. 1998. PMID: 9582019 - The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
Chai YL, Cui J, Shao N, Shyam E, Reddy P, Rao VN. Chai YL, et al. Oncogene. 1999 Jan 7;18(1):263-8. doi: 10.1038/sj.onc.1202323. Oncogene. 1999. PMID: 9926942 - Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer.
Okumura N, Yoshida H, Kitagishi Y, Nishimura Y, Matsuda S. Okumura N, et al. Biochem Biophys Res Commun. 2011 Sep 30;413(3):395-9. doi: 10.1016/j.bbrc.2011.08.098. Epub 2011 Aug 27. Biochem Biophys Res Commun. 2011. PMID: 21893034 Review. - BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer.
Tammaro C, Raponi M, Wilson DI, Baralle D. Tammaro C, et al. Biochem Soc Trans. 2012 Aug;40(4):768-72. doi: 10.1042/BST20120140. Biochem Soc Trans. 2012. PMID: 22817731 Review.
Cited by
- BRCA1-No Matter How You Splice It.
Li D, Harlan-Williams LM, Kumaraswamy E, Jensen RA. Li D, et al. Cancer Res. 2019 May 1;79(9):2091-2098. doi: 10.1158/0008-5472.CAN-18-3190. Epub 2019 Apr 16. Cancer Res. 2019. PMID: 30992324 Free PMC article. Review. - Transactivation of the estrogen receptor promoter by BRCA1.
Archey WB, Arrick BA. Archey WB, et al. Cancer Cell Int. 2017 Mar 2;17:33. doi: 10.1186/s12935-017-0401-2. eCollection 2017. Cancer Cell Int. 2017. PMID: 28270739 Free PMC article. - The ETS family transcription factor ELK-1 regulates induction of the cell cycle-regulatory gene p21(Waf1/Cip1) and the BAX gene in sodium arsenite-exposed human keratinocyte HaCaT cells.
Shin SY, Kim CG, Lim Y, Lee YH. Shin SY, et al. J Biol Chem. 2011 Jul 29;286(30):26860-72. doi: 10.1074/jbc.M110.216721. Epub 2011 Jun 3. J Biol Chem. 2011. PMID: 21642427 Free PMC article. - Examination of the expanding pathways for the regulation of p21 expression and activity.
Jung YS, Qian Y, Chen X. Jung YS, et al. Cell Signal. 2010 Jul;22(7):1003-12. doi: 10.1016/j.cellsig.2010.01.013. Epub 2010 Jan 25. Cell Signal. 2010. PMID: 20100570 Free PMC article. Review. - Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.
Maniccia AW, Lewis C, Begum N, Xu J, Cui J, Chipitsyna G, Aysola K, Reddy V, Bhat G, Fujimura Y, Henderson B, Reddy ES, Rao VN. Maniccia AW, et al. J Cell Physiol. 2009 Jun;219(3):634-41. doi: 10.1002/jcp.21708. J Cell Physiol. 2009. PMID: 19170108 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous